Sprint Bioscience (Sweden) Math Transform Price Natural Logarithm

SPRINT Stock  SEK 1.93  0.04  2.12%   
Use the math transform workspace to apply Price Natural Logarithm transformation and other studies to Sprint Bioscience. The focus on price transformations that reveal shifts in trend structure helps organize trend, volatility, and risk context for Sprint Bioscience.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Sprint Bioscience Price Natural Logarithm is logarithm with base 'e' where e is equal to 2.718281828. It is applied on the entire Sprint Bioscience pricing series.

Sprint Bioscience Technical Analysis Modules

Most technical analysis of Sprint Bioscience help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sprint from various momentum indicators to cycle indicators. When you analyze Sprint charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. As a micro-cap equity, Sprint Bioscience is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/E of 32.79, P/B of 2.61. Sprint Bioscience has a market cap of 53.17 M, P/E of 32.79, ROE of -109.26%.

Methodology

Unless otherwise specified, financial data for Sprint Bioscience AB is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Sprint (SE:SPRINT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Sprint Bioscience AB is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR. Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Sprint Bioscience AB may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board

Become your own money manager

Tracking Sprint Bioscience inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Momentum Idea
Momentum
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Advertising Idea
Advertising
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
Social Domain Idea
Social Domain
Invested few shares
FinTech Idea
FinTech
Invested over 20 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares

More Resources for Sprint Stock Analysis

Other Information on Investing in Sprint Stock

Financial ratios for Sprint Bioscience provide valuation context across profits, cash flow, and enterprise value. They help compare Sprint across valuation measures and peers.